Andrew L. Kleinhenz

Chronic Low Dose Oral Exposure to Microcystin-LR Exacerbates Hepatic Injury in a Murine Model of Non-Alcoholic Fatty Liver Disease

Apurva Lad, Robin C. Su, Joshua D. Breidenbach et al. · Toxins · 2019 · 48 citations · Full text

Pharmacy, Pharmacology, Toxicology +17

Exposure to the Harmful Algal Bloom (HAB) Toxin Microcystin-LR (MC-LR) Prolongs and Increases Severity of Dextran Sulfate Sodium (DSS)-Induced Colitis

Robin C. Su, Thomas Blomquist, Andrew L. Kleinhenz et al. · Toxins · 2019 · 39 citations · Full text

Veterinary Medicine, Toxicology, Environmental Toxicology +16

Microcystin-LR aerosol induces inflammatory responses in healthy human primary airway epithelium

Joshua D. Breidenbach, Benjamin W. French, Tamiya T. Gordon et al. · Environment International · 2022 · 34 citations · Full text

Pharmacy, Microbiology, Toxicology +17

Hyperglycemia induces key genetic and phenotypic changes in human liver epithelial HepG2 cells which parallel the Leprdb/J mouse model of non-alcoholic fatty liver disease (NAFLD)

Robin C. Su, Apurva Lad, Joshua D. Breidenbach et al. · PLoS ONE · 2019 · 32 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +15

Assessment of diagnostic biomarkers of liver injury in the setting of microcystin-LR (MC-LR) hepatotoxicity

Robin C. Su, Apurva Lad, Joshua D. Breidenbach et al. · Chemosphere · 2020 · 32 citations

Pharmacy, Clinical Toxicology, Toxicology +14